Our Science – Dimitrov Website
Dimiter S. Dimitrov, Ph.D.
Selected Publications |
 |
| 1)
Tang Z, Feng M, Gao W, Phung Y, Chen W, Chaudhary A, Croix BS, Qian M, Dimitrov DS, Ho M. A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface. Mol. Cancer Ther. [Epub ahead of print], 2013. [Journal] |
|
| 2)
Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ. Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood. 121: 1165-74, 2013. [Journal] |
|
| 3)
Chen W, Ying T, Dimitrov DS. Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design. Expert Opin Biol Ther. 13: 657-71, 2013. [Journal] |
|
| 4)
Zhu Z, Prabakaran P, Chen W, Broder CC, Gong R, Dimitrov DS. Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1. Virol Sin. 28: 71-80, 2013. [Journal] |
|
| 5)
Meyerson JR, Tran EE, Kuybeda O, Chen W, Dimitrov DS, Gorlani A, Verrips T, Lifson JD, Subramaniam S. Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives. Proc. Natl. Acad. Sci. U.S.A. 110: 513-8, 2013. [Journal] |
|
| 6)
Feng M, Gao W, Wang R, Chen W, Man YG, Figg WD, Wang XW, Dimitrov DS, Ho M. Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 110: E1083-91, 2013. [Journal] |
|
| 7)
Feng Y, Dimitrov DS. Antibody-based therapeutics against components of the IGF system. Oncoimmunology. 1: 1390-1391, 2012. [Journal] |
|
| 8)
Gong R, Wang Y, Ying T, Dimitrov DS. Bispecific Engineered Antibody Domains (Nanoantibodies) That Interact Noncompetitively with an HIV-1 Neutralizing Epitope and FcRn. PLoS ONE. 7: e42288, 2012. [Journal] |
|
| 9)
Gong R, Chen W, Dimitrov DS. Candidate Antibody-Based Therapeutics Against HIV-1. BioDrugs. 26: 143-62, 2012. [Journal] |
|
| 10)
Varewijck AJ, Brugts MP, Frystyk J, Goudzwaard JA, Uitterlinden P, Waaijers AM, Feng Y, Dimitrov DS, Lamberts SW, Hofland LJ, Janssen JA. Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling. Mol. Cell. Endocrinol. [Epub ahead of print], 2012. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/22/2013.
